Hormonal contraception and the risk of HIV acquisition
Advances in Nursing & Midwifery,
Vol. 25 No. 91 (2016),
10 Dey 2016
,
Page 1-9
https://doi.org/10.22037/anm.v25i91.11432
Abstract
Abstract
Introduction:
More than 100 million women worldwide use hormonal contraceptive, including using DMPA or
oral contraceptive. There is particular concern about a putative link between hormonal
contraception and HIV infection. The aim of this review article was to evaluate the association
between hormonal contraception use and risk of HIV infection
Methods:
We were retrieved through a systematic search of electronic databases such as PubMed, Science
Direct, Elsevier, BMJ, JAMA by utilizing keywords HIV prevention, hormonal contraception,
women's` health, risk factors and human immunodeficiency virus (HIV). This search conducted for
relevant literature published between 1989 and 2013.
Finding:
An estimated 40 million people live with human immunodeficiency virus (HIV) globally. Most HIV
infected human are of reproductive age 15–49 years. Approximately 45% of women using
hormonal contraceptions. Long term used of Progestin-only Injectable such as DMPA and NETEN,
may cause thinning of cervico-vaginal mucosa, it may lead to abrasions that facilitate access of
HIV to CD4+ target cells in submucosal tissue and increased simian immunodeficiency virus
acquisition. Although the clinical significance of this thinning remains uncertain.
Conclusions:
The data do not support an association between use of oral contraceptives and increased risk of
HIV acquisition. Nonetheless, family planning services are an important venue for HIV prevention
activities
Keywords:
Hormonal Contraception, HIV, Risk Factors, Women Health
- Hormonal Contraception
- HIV
- Risk Factors
- Women Health
How to Cite
References
‐ Baeten J M, et al. (2007) Hormonal contraceptive use, herpes simplex virus infection, and risk
of HIV-1 acquisition among Kenyan women. AIDS. 21(13) 1771-7.
‐ Bahamondes L, et al. (2000) The effect upon the human vaginal histology of the long-term use
of the injectable contraceptive Depo-Provera. Contraception. 62(1) 23–27.
‐ Beksinska M E, et al. (2001) Bone mineral density in adolescents using norethisterone
enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for
contraception. Contraception. 75(6) 438‐43.
‐ Brown J M, et al. (2007) Incident and prevalent herpes simplex virus type 2 infection increases
risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS. 21(12) 1515–23.
‐ Bulterys M, et al. (1994) .Incident HIV-1 infection in a cohort of young women in Butare,
Rwanda. AIDS. 8(11) 1585–91.
‐ Castilla J, et al. (2005) Effectiveness of highly active antiretroviral therapy in reducing
heterosexual transmission of HIV. Journal of Acquired Immune Deficiency Syndrome. 40(1) 96–101.
‐ Chen J L, et al. (2001) Fertility desires and intentions of HIV- positive men and women. Family
Planning Perspectives. 33(4) 144-152+165
‐ Chen L I, et al. (2007) Sexual risk factors for HIV infection in early and advanced HIV
epidemics in sub-Saharan Africa: systematic overview of 68 epidemiological studies. Plos One.
(10) e1001.
‐ Critchlow C W, et al. (1995) Determinants of cervical ectopia and cervicitis: age, oral
contraception, specific cervical infection, smoking and douching. American Journal Obsteteric
Gynecology. 173(2) 534–43.
‐ Crook A, et al. (2014) Injectable and oral contraceptives and risk of HIV acquisition in women:
an analysis of data from the MDP301 trial. Human Reproduction. 29(8) 1810-1817.
‐ Debiaggi M, et al. (2001) Viral extraction in cervicovaginal secretions of HIV-1-infected
women receiving antiretroviral therapy. European Journal of Clinical Microbiology and Infectious
Diseases. 20(2) 91–96.
‐ Delvaux T, Buvé A (2013) Hormonal contraception and HIV acquisition - what is the evidence?
What are the policy and operational implications? (Abstract) The European Journal of
Contraception and Reproductive Health Care. 18(1) 15-26.
‐ Deschamps MM, Pape JW, Hafner A (1996) Heterosexual transmission of HIV in Haiti. Annals
Internal Medicine. 125(4) 324–330.
‐ Galvin S, Cohen M (2004) The role of sexually transmitted diseases in HIV transmission. Nature
reviews. Microbiology. 2(1) 33–42.
‐ Gupta P, et al. (1997) High viral load in semen of human immunodeficiency virus type 1-
infected men at all stages of disease and its reduction by therapy with protease and
nonnucleoside reverse transcriptase inhibitors. Journal of Virology. 71(8) 6271–75.
‐ Gray R H, et al. (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a
randomized trial. Lancet. 369(9562) 657–666.
‐ Heikinheimo O, et al. (2006) The levonorgestrel-releasing intrauterine system (LNG-IUS) in
HIV-infected women-effects on bleeding patterns, ovarian function and genital shedding of HIV.
Human Reproduction. 21(11) 2857–2861.
/ سال 25 ، شماره 91 ، زمستان 1394 شهين سوادزاده و همكاران
‐ Hild-Petito S, et al. (1998) Effects of two progestin-only contraceptives, Depo-Provera and
Norplant-II, on the vaginal epithelium of rhesus monkeys. AIDS Research Human Retroviruses.
(1) S125–S130.
‐ Huijbregts R P, et al. (2013) Hormonal contraception and HIV-1 infection: medroxyprogesterone
acetate suppresses innate and adaptive immune mechanisms. Endocrinology. 154(3) 1282-1295.
‐ Kleinschmidt I, et al. (2007) Injectable progestin contraceptive use and risk of HIV infection in a
South African family planning cohort. Contraception. 75 (6) 461–467.
‐ Kongnyuy EJ, Soskolne V, Adler B (2008) Hormonal contraception, sexual behaviour and HIV
prevalence among women in Cameroon. BMC Women's Health. 8(19) 1-6.
‐ Laga M, et al. (1993) Non-ulcerative sexually transmitted diseases as risk factors for HIV-1
transmission in women: results from a cohort study. Acquired Immune Deficiency Syndrome.
(1) 95–102.
‐ Louv WC, et al. (1989) Oral contraceptive use and the risk of chlamydial and gonococcal
infections. Amrican Journal Obsteteric Gynecology. 160(2) 396–402.
‐ Mauck C, et al. (1999) The effect of one injection of Depo-Provera on the human vaginal
epithelium and cervical ectopy. Contraception. 60(1) 15–24.
‐ McCoy S I, et al (2013).Oral and injectable contraception use and risk of HIV acquisition among
women in sub-Saharan Africa. AIDS. 27(6) 1001-1009.
‐ Morrison C S, et al. (2007) Hormonal contraception and the risk of HIV acquisition. Acquired
Immune Deficiency Syndrome. 21(1) 85-95.
‐ Myer L, et al. (2007) Prospective study of hormonal contraception and women’s risk of HIV
infection in South Africa. International Journal of Epidemiology. 36(1) 166 –174.
‐ Overton E T, et al. (2008) Incidence of sexually transmitted infections among HIV-infected
women using depot medroxyprogesterone acetate contraception. Contraception. 78(2) 125-30.
‐ -Padian NS (1998). Recent findings about the heterosexual transmission of HIV and AIDS.
Current Opinion Infection Disease. 11(1) 9-12.
‐ Pilcher C D, et al. (2007) Amplified transmission of HIV-1: comparison of HIV-1 concentrations
in semen and blood during acute and chronic infection. AIDS. 21(13) 1723-30.
‐ Plourde P J, et al. (1994) Human immunodeficiency virus type 1 seroconversion in women with
genital ulcers. Journal Infection Disease. 170(2) 313–317.
‐ Plummer F A, et al. (1991) Cofactors in male-female sexual transmission of human
immunodeficiency virus type 1. Journal Infection Disease. 163(2) 233–39.
‐ Prakash M, et al. (2002) Oral contraceptive use induces upregulation of the CCR5 chemokine
receptor on CD4+ T cells in the cervical epithelium of healthy women. Journal Reproduction
Immunology. 54(1-2) 117–131.
‐ Pudney J, Quayle AJ, Anderson DJ (2005) Immunological microenvironments in the human
vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation
zone. Biology Reproduction. 73(6) 1253–1263.
‐ Polis C B, Curtis K M (2013) Use of hormonal contraceptives and HIV acquisition in women: a
systematic review of the epidemiological evidence. Lancet Infect Dis. 13(9) 797-808.
‐ Quinn T C, et al. (2000) Viral load and heterosexual transmission of human immunodeficiency
virus type 1. Rakai Project Study Group. New England Journal OF Medicine. 342 (13) 921–929.
/ HIV نشريه دانشكده پرستاري و مامايي روش هاي پيشگيري از بارداري هورموني و خطر ابتلا به ويروس
‐ Rehle T, et al. (1992) Risk factors of HIV-1 infection among female prostitutes in Khon Kaen,
northeast Thailand. Infection. 20(6) 328–331
‐ Simon V, et al. (2006) HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.
Lancet. 368 (9534) 489–504.
‐ -Shattock R J ,Moore J P (2003) Inhibiting sexual transmission of HIV-1 infection. Nature
Reviews Microbiology. 1(1) 25–34.
‐ Shah I (2005) Contraceptive use patterns in countries with different levels of HIV epidemic.
Journal Acquired Immune Deficency Syndrome. 38(1) S5-8.
‐ Ungchusak K, et al. (1996) Determinants of HIV infection among female commercial sex
workers in northeastern Thailand: results from a longitudinal study. Journal Acquired Immune
Deficiency Syndrome Human Retrovirlogy. 12(5) 500–507.
‐ Van Leeuwen E, et al. (2007) Reproduction and fertility in human immune deficiency virus type-
infection. Human Reproduction Update. 13(2) 197–206.
‐ Watts D H, et al. (2008) Safety and tolerability of depot medroxyprogesterone acetate among
HIV-infected women on antiretroviral therapy: ACTG A5093. Contraception. 77(2) 84–90.
‐ WHO. (2008) "Operational guidance for scaling up male circumcision services for HIV
prevention". [Online]
http://whqlibdoc.who.int/publications/2007/9789241595988_eng.pdf> [accessed Jun 2016).
- Abstract Viewed: 615 times
- PDF Downloaded: 347 times